Pelage Pharmaceuticals

Pelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments

Pelage Pharmaceuticals Appoints New Board Member and Promotes Key Executives In the competitive landscape of regenerative medicine, where innovative solutions for hair loss are increasingly in demand, Pelage Pharmaceuticals is making strategic moves to solidify its position. The company, a clinical-stage biotechnology…

Read MorePelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments
Bristol Myers Squibb

Bristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl

Positive Top-Line Results for Reblozyl in Alpha-Thalassemia Study Is the treatment landscape for alpha-thalassemia about to change? Bristol Myers Squibb has announced positive top-line results from an ongoing, ex-US, Phase 2 registrational study evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia in adults…

Read MoreBristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl
Epredia

Gilead Sciences Acquires Arcellx for $7.8 Billion to Advance Cancer Immunotherapies

Gilead Sciences Seals $7.8 Billion Deal for Arcellx to Boost CAR T-Cell Therapy In the rapidly evolving landscape of cancer immunotherapies, where breakthroughs are crucial for patient outcomes, Gilead Sciences, Inc. has made a significant move. The biopharmaceutical giant has announced a…

Read MoreGilead Sciences Acquires Arcellx for $7.8 Billion to Advance Cancer Immunotherapies
AOP Health

AOP Health Advances Rare Disease Care With Collaborative Data and Patient Engagement

AOP Health Emphasizes Collaboration and Patient-Centered Information on Rare Disease Day 2026 Why is the diagnosis and treatment of rare diseases so challenging? AOP Health, a global enterprise group with roots in Austria, is dedicated to addressing this critical issue.…

Read MoreAOP Health Advances Rare Disease Care With Collaborative Data and Patient Engagement
Virion Therapeutics

Virion Therapeutics Advances HBV Functional Cure With Novel Immunotherapy

Virion Therapeutics Unveils Promising HBV Treatment at CROI Conference Is the global fight against chronic hepatitis B (CHB) finally turning a corner? Virion Therapeutics, LLC, a clinical-stage biotechnology company, is making significant strides with its novel T cell-based immunotherapy, VRON-0200.…

Read MoreVirion Therapeutics Advances HBV Functional Cure With Novel Immunotherapy
Exact Sciences Corporation

Exact Sciences Corporation Secures Shareholder Approval for Abbott Acquisition

Exact Sciences Corporation Gains Overwhelming Shareholder Support for Abbott Deal In the rapidly evolving landscape of cancer diagnostics, where precision and speed are paramount, Exact Sciences Corporation has taken a significant step forward. The company, a leading provider of cancer…

Read MoreExact Sciences Corporation Secures Shareholder Approval for Abbott Acquisition
Science Corporation

Science Corporation and Neurosoft Bioelectronics Partner to Accelerate BCI Innovation

Science and Neurosoft Team Up to Reduce BCI Development Costs and Time Science Corporation, a pioneering full-stack neural engineering company, and Neurosoft Bioelectronics, a neural data company, have announced a strategic partnership to grant Neurosoft access to Science’s full stack…

Read MoreScience Corporation and Neurosoft Bioelectronics Partner to Accelerate BCI Innovation

ALIS Releases First-of-Its-Kind Clinical Benchmarking Report for Senior Living

ALIS Unveils Comprehensive Clinical and Operational Insights for Senior Living Communities In an industry where data-driven decisions can mean the difference between thriving and merely surviving, ALIS is setting a new standard. The leading senior living intelligent eHR software company…

Read MoreALIS Releases First-of-Its-Kind Clinical Benchmarking Report for Senior Living